Research use only — not for human or veterinary use
Semaglutide Peptide For Sale — 5 mg and 10 mg Research Vials
Semaglutide is a 31-amino-acid GLP-1 receptor agonist derived from the native human GLP-1(7-37) sequence, with an aminoisobutyric acid substitution at position 8 and a C18 fatty diacid chain attached through a short spacer. Those two modifications are the whole story of the molecule: the substitution blocks DPP-4 cleavage and the acyl chain drives albumin binding, together turning a peptide with a minutes-long native half-life into one that survives long incubations. For laboratories, semaglutide is the canonical single-target GLP-1 tool — the baseline against which dual and triple agonists are measured. Research use only; not for human or veterinary use.
Compare Semaglutide Research Vials
Both listings are lyophilized research vials supplied with bacteriostatic water for reconstitution. Choose the strength that matches your planned concentration range and study length.
| Option | Format | Suited to | Product page |
|---|---|---|---|
| 5 mg vial | Lyophilized powder, single research vial | Pilot assays, method development, short bench protocols | View 5 mg vial → |
| 10 mg vial | Lyophilized powder, single research vial | Multi-plate comparative panels and longer study arcs | View 10 mg vial → |
What Is Semaglutide?
Semaglutide is an engineered analog of glucagon-like peptide-1, the incretin hormone released from intestinal L-cells. Native GLP-1 is cleaved almost immediately by dipeptidyl peptidase-4 at the alanine in position 8; semaglutide replaces that residue with α-aminoisobutyric acid, which the enzyme cannot process. The second modification, an octadecanedioic acid chain joined via a γ-glutamic acid and two short PEG-like spacers at lysine-26, provides reversible binding to serum albumin.
The result is a peptide that behaves very differently in the lab from native GLP-1. Where native GLP-1 assays must be run quickly and in enzyme-inhibited buffer, semaglutide tolerates long incubations in serum-containing media. That practical durability, more than any single potency figure, is why it displaced native GLP-1 as the working reference agonist in most in vitro incretin protocols.
It remains a pure mono-agonist: it engages the GLP-1 receptor and does not meaningfully activate the GIP or glucagon receptors. That selectivity is precisely what makes it useful as a control arm in studies of multi-receptor compounds.
GLP-1 Receptor Signalling in Study Models
The GLP-1 receptor is a class B GPCR coupling primarily to Gs. Agonist occupancy raises intracellular cyclic AMP, activates protein kinase A and Epac2, and — in islet-cell models — modulates the downstream calcium handling that laboratories track with fluorescent indicators. Semaglutide produces steep, reproducible cAMP dose-response curves, which is why it is a common positive control for plate validation.
Semaglutide also recruits β-arrestin and drives receptor internalisation more readily than biased or imbalanced agonists. Researchers studying receptor trafficking use it as the high-internalisation reference point, imaging surface receptor loss over time and comparing that trajectory against compounds engineered for reduced arrestin engagement.
Central-signalling models focus on hindbrain and hypothalamic GLP-1 receptor populations. In those systems the questions are typically about receptor distribution and downstream neuronal activation markers rather than about the peptide itself, and semaglutide is used because its stability makes long incubations tractable.
Where Semaglutide Fits in a Research Programme
Most laboratories that buy semaglutide are not studying semaglutide in isolation. They are using it as the reference arm in comparative incretin work: semaglutide versus tirzepatide to isolate the GIP contribution, semaglutide versus cagrilintide to contrast incretin and amylin signalling, semaglutide versus retatrutide to bracket the full mono-to-triple agonist range.
It is also the compound of choice for analytical method development. Because it is widely available at consistent quality and has well-characterised chromatographic behaviour, it is a practical system-suitability standard when validating an HPLC or LC-MS method that will later be applied to less well-behaved analogs.
A third application is formulation research: acylated peptides interact with container surfaces, surfactants, and carrier proteins in ways that plain peptides do not, and semaglutide is the best-documented member of that class for anyone characterising those interactions.
- Reference GLP-1 agonist arm in comparative panels
- Positive control for cAMP and calcium assay validation
- Receptor internalisation and trafficking studies
- Analytical system-suitability and method-development standard
Choosing Between the 5 mg and 10 mg Vial
The choice is a function of total peptide mass required, not of potency — the material is identical. A 5 mg vial suits pilot work, single-plate assays, and method development where the priority is minimising the amount of material sitting reconstituted in a fridge. Peptide in solution has a shorter usable window than peptide in the lyophilized cake, so buying the smallest vial that covers a protocol is usually the more rigorous choice.
The 10 mg vial makes sense when a study runs multiple plates, multiple concentration series, or several weeks of scheduled sampling, and when the laboratory intends to aliquot immediately after reconstitution. It reduces the number of vial openings, each of which is a contamination and moisture-ingress opportunity.
Both listings ship with bacteriostatic water. Our reconstitution calculator converts a target working concentration and vial strength into the required diluent volume, which avoids the arithmetic error that accounts for most reported concentration discrepancies.
Handling, Reconstitution and Stability
Store sealed vials frozen for long-term holding, or at 2–8 °C for shorter periods, always protected from light and moisture. Bring the vial to room temperature before opening so condensation does not reach the cake; a lyophilisate that has taken on water will dissolve unevenly and produce a lower effective concentration than the label mass implies.
Add diluent slowly against the glass wall and swirl gently until clear. Do not shake. Acylated peptides foam readily, and foam is peptide stranded at an air-liquid interface rather than dissolved in the working volume. A properly reconstituted solution should be clear and free of visible particulates.
Once in solution, keep the vial refrigerated, log the reconstitution date on the vial itself, and prefer single-use aliquots over repeated withdrawals from one container. Where a study spans weeks, aliquoting and freezing at the point of reconstitution gives far more consistent data than drawing repeatedly from a single stock.
Material Specifications
- Compound
- Semaglutide
- Class
- GLP-1 receptor agonist (mono-agonist)
- Molecular formula
- C187H291N45O59
- Molar mass
- ≈ 4,113 g/mol
- Appearance
- White to off-white lyophilized powder
- Purity
- ≥ 99% by reverse-phase HPLC
- Storage
- Frozen or 2–8 °C sealed; reconstituted 2–8 °C
- Use
- In vitro laboratory research only
Purity, Testing & Certificates of Analysis
Semaglutide batches are released against reverse-phase HPLC purity criteria with mass-spectrometry identity confirmation. Because the acyl side chain is the modification most likely to vary between synthesis runs, our release review looks specifically at the related-substance profile around the main peak rather than only at the integrated purity percentage.
Every order references a dated Certificate of Analysis tied to the specific lot shipped, recording purity, identity, water content, appearance, and assay date. Certificates remain accessible after purchase so they can be attached to a study record or an internal QA file later.
Certificates for the full catalogue are published in our COA library. If a lot number on a vial does not match a retrievable certificate, contact us before using the material in a study.
Research FAQ
What is semaglutide used for in laboratory research?
Semaglutide is used as the reference GLP-1 receptor agonist in in vitro research: cAMP and calcium signalling assays, receptor internalisation studies, comparative incretin panels, and analytical method development. It is supplied as a research chemical only, not for human or veterinary use, and we provide no dosing guidance.
What is the difference between the 5 mg and 10 mg semaglutide vials?
Only the total peptide mass in the vial. The material, purity specification, and documentation are identical. Choose 5 mg for pilot assays and method development, and 10 mg for multi-plate comparative work or longer study arcs where fewer vial openings and immediate aliquoting are preferable.
How does semaglutide differ from native GLP-1?
Native GLP-1 is cleaved within minutes by DPP-4. Semaglutide substitutes α-aminoisobutyric acid at position 8 to block that cleavage and adds a C18 fatty diacid chain that binds albumin reversibly. In the lab this means semaglutide tolerates long incubations in serum-containing media where native GLP-1 does not.
What purity is your semaglutide?
Semaglutide is released at ≥99% chromatographic purity by reverse-phase HPLC with mass-spec identity confirmation, and each lot ships against a dated, lot-specific Certificate of Analysis recording purity, identity, water content, and appearance.
How should semaglutide be reconstituted and stored?
Bring the sealed vial to room temperature, add bacteriostatic water slowly down the glass wall, and swirl gently until clear — never shake. Store the reconstituted solution at 2–8 °C protected from light, log the reconstitution date, and prefer single-use aliquots over repeated withdrawals.
Can semaglutide be used as a control against tirzepatide?
Yes. Because semaglutide is a selective GLP-1 mono-agonist and tirzepatide additionally engages the GIP receptor, running both in the same plate with a shared vehicle control is the standard way to attribute an observed signalling difference to the GIP arm rather than to assay drift.
Where do semaglutide orders ship from?
All orders are fulfilled from our Jacksonville, Florida facility with same-business-day dispatch before the daily cut-off. Domestic transit is typically one to two business days, and packaging is selected to protect the lyophilisate through the expected transit profile.
Is semaglutide legal to purchase for research?
It is supplied strictly as a research chemical for qualified in vitro laboratory use. It is not a medicine, dietary supplement, or product for human or veterinary consumption, and purchasers are responsible for complying with the regulations that apply in their jurisdiction and institution.
Research Resources
All products listed are supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary use. We do not provide dosing guidance or therapeutic recommendations, and nothing on this page describes a diagnosis, treatment, cure, or prevention of any condition.